Back
PAROA
Paradigm Biopharmaceuticals Limited.
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
31
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Paradigm Biopharmaceuticals Limited. - Option Expiring 11-Feb-2026
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.07
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PAROA
31
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in PAROA
67 days
PAROA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
10%
100k - 150k
8%
50k - 100k
46%
Less than 50k
28%
👶 Age of investors
18 - 25
26 - 34
32%
35 - 90
65%
🙋 Legal gender of investors
Female
52%
Male
48%
Pearlers who invest in PAROA also invest in...
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-19. The firm is engaged in discovering, developing, and delivering pharmaceutical therapies. The company is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). The company develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).
🙌 Performance (5Yr p.a)
-17.81%
📊 Share price
$0.29 AUD
🧬 BIOTECHNOLOGY
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
9.20%
📊 Share price
$106.20 AUD
🇦🇺 AUSTRALIA
🧱 MATERIALS
💸 FINANCIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
22.26%
📊 Share price
$61.37 AUD
📈 HIGH PRICE GROWTH
💰 HIGH DIVIDEND
🇺🇸 UNITED STATES
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.06%
📊 Share price
$69.80 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery Value‑Chain Index (the “Index”).
🙌 Performance (5Yr p.a)
12.64%
📊 Share price
$86.49 AUD
🌏 GLOBAL
🏭 INDUSTRIALS
🧱 MATERIALS
🤖 TECHNOLOGY
🛍️ CONSUMER
📈 HIGH PRICE GROWTH
Want more shares? Try these...
Patriot Lithium Ltd. provides exploration services. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2022-12-09. Its projects include Ontario Lithium Projects, Black Hills Lithium Projects and Zambian Copper Projects. Its Ontario Lithium Projects and Black Hills Lithium Projects are a high-grade, hard rock lithium project portfolio. Its Ontario Lithium Projects include Gorman Project, Birkett Project, Dryden Project and Bull Project. The Gorman Project covers 506 square kilometers (km2). The Birkett Project comprises six mining claims for a total area of 25 km2. Its Black Hills Lithium Projects include Tinton West Project (South Dakota/Wyoming) and Keystone Project (South Dakota). The Keystone Project comprises 255 unpatented lode mining claims. The company has option agreements to enter into farm-in agreements to acquire interests in the Katwaro Copper Project, Jisanshi Copper Project and Kitumba Copper Project 27715. The company also has an option agreement to acquire a 90% interest in three large scale exploration licenses in the copper rich Mumbwa Region.
📊 Share price
$0.06 AUD
⛏️ MINING
